2016075__Amendment_1_Final.pdf

AMENDMENT #1, RFP No. NIAID-DAIDS-NIHAI2016075

Amendment No. 1

RFP No. NIAID-DAIDS-NIHAI2016075

“Nonhuman Primate Core Virology Laboratory for

AIDS Vaccine Research and Development”

Solicitation Number:

Amendment Number:

Amendment Issue

Date:

NIAID-DAIDS-NIHAI2016075

One (1)

January 19, 2017

Response Date:

Thursday, February 15, 2017 at 3:00 PM, Local Time

(Unchanged)

Issued By: Michelle L. Scala

Contracting Officer

OA/DEA/NIAID/NIH/DHHS

5601 Fishers Lane, Room 3D10, MSC 9821

Bethesda, Maryland 20892-9821

Points of Contact: PRIMARY:

kim.brookens@nih.gov

Kim Brookens, Contract Specialist

Phone: 301-761-5140

SECONDARY:

mscala@niaid.nih.gov

Michelle L. Scala, Contracting Officer

Phone: 240-669-5156

The purpose of this amendment is to answer a question from a potential offeror regarding the solicitation.

Offerors must acknowledge receipt of this amendment by identifying this amendment number and date of the amendment on each copy of the proposal submitted. Failure to receive your acknowledgement may result in the rejection of your proposal. Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.

Question from Potential Offeror:

mailto:kim.brookens@nih.gov mailto:anhughes@niaid.nih.gov

AMENDMENT #1, RFP No. NIAID-DAIDS-NIHAI2016075

Question 1:

In the SOW it states that at the written request of the COR, we can improve current assays or develop new assays to quantitate viral nucleic acids. Do you mean from this statement to include assays to quantitate the viral reservoir?

Response to Question 1:

Assays to measure the viral reservoir are time consuming and thus, cost prohibitive. This contract does not have the resources to improve or develop a new assay to quantitate the viral reservoir, specifically. As such, offerors are not expected to have this capability or to budget for this work.